All lobbying filings

AEGIS LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Biopharmaceutical industry trade association.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 2, 2026

Official filing document

Bills named in this filing 6

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 5378
Lower Costs, More Transparency Act
HR 5376
Share the Savings with Seniors Act
HR 6283
DRUG Act
S 1542
DRUG Act
HR 830
HELP Copays Act

Lobbying activity 2

Pharmacy

Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.

Health Issues

General health care issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.